mBIOTA Labs

What mBIOTA Labs does

mBIOTA Labs is a Santa Monica-based, direct-to-consumer medical food company founded in 2021 by Krystyna Houser, a patient with personal experience of GI disorders who partnered with Cedars-Sinai gastroenterologists Dr. Mark Pimentel and Dr. Ali Rezaie to commercialize a clinically validated elemental diet. The company sells a portfolio of powdered elemental nutrition products centered on the mBIOTA Elemental Diet 2-Week Protocol ($750, 84 servings), with a 1-Week Extension ($375) and a Maintenance Plan ($250). The underlying technology is a pre-digested nutrient formula (free amino acids, simple carbohydrates, MCTs) absorbed in the proximal small intestine to rest the gut, using the company's proprietary Amino Taste Modification Technology (ATMT) to overcome the palatability barrier that has historically driven low compliance in elemental diets. The formula is vegan, gluten-free, lactose-free, and free of artificial sweeteners.

The business targets four primary patient populations: SIBO/IMO, IBS, IBD (Crohn's/Ulcerative Colitis), and EoE patients. A 2023 prospective clinical trial at Cedars-Sinai demonstrated 83% SIBO eradication and 100% protocol completion among enrolled patients, with results published in Clinical Gastroenterology and Hepatology. Quantitative claims also include up to 82% reduction in 12 common GI symptoms, 71% of Crohn's patients achieving clinical remission at 4 weeks, and 88% of EoE patients showing histologic improvement, sourced from referenced studies. The company markets primarily through its own e-commerce site, supported by content marketing (The Digest blog), organic social (Instagram, YouTube, TikTok), webinars, press coverage, and a free 15-minute concierge support call staffed by Registered Nurses and clinical specialists.

Revenue is generated through one-time direct product purchases and recurring subscriptions (10-20% subscription discount, with 3-shipment minimum), supplemented by a Trumed partnership that enables HSA/FSA payment. The company has supported over 5,000 patients, achieved a 4.15-4.2 star customer rating across 93 verified reviews, and operates with 1-10 employees from a single Santa Monica headquarters. Related entity GoodLFE extends the post-protocol transition experience through Low Fermentation Eating resources.

Name

mBIOTA Labs

Legal name

mBIOTA Labs

Website

https://mbiota.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

mBIOTA Labs is a direct-to-consumer medical food company selling clinically validated elemental diet protocols for patients with SIBO, IBS, IBD, and EoE, using proprietary Amino Taste Modification Technology to overcome palatability barriers and improve treatment compliance.

Ownership category

akta.pro rank

Product category

Medical Nutrition Foods

NAICS

Food (Health) Supplement Retailers (456191)

SIC

Miscellaneous Food Preparations & Kindred Products (2090)

akta.pro primary industry

Gut Health & Digestive Nutrition (IBS, GERD, Elimination Diets) (HSADAFAH)

akta.pro secondary industries

Special-Diet & Functional Prepared Meals (Keto, Vegan, Gluten-Free, Medical) (CRAHAJAG), Medical Nutrition & Meal Replacement (RTD, Bars, Powders) (CRADAGAN)

Keywords

• Elemental diet products
• Medical nutrition food
• Digestive health support
• GI condition therapy
• Patient wellness products

Headquarters

HQ city

Santa Monica

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain

Revenue model

1. Direct Product Sales: mBIOTA sells elemental diet protocol kits directly to consumers through their e-commerce website. Products include 2-Week Protocol (84 servings), 1-Week Extension (42 servings), and Maintenance Plan (24 servings). One-time purchase and subscription options available.
2. Subscription Recurring Revenue: Customers can subscribe to receive products automatically every 3 months (2-Week Protocol with 10% savings) or monthly (1-Week Extension and Maintenance Plan with 20% savings). Subscriptions require minimum 3 shipments before cancellation eligibility.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

mBIOTA Labs develops and sells the mBIOTA Elemental Diet, a medical food product line of pre-digested, sole-source nutrition (free amino acids, simple carbohydrates, and MCTs) used under medical supervision to rest the gut and address gastrointestinal conditions such as SIBO, IMO, IBS, IBD, and EoE. The portfolio is anchored by the 2-Week Protocol (84 servings) with supporting 1-Week Extension and Maintenance Plan offerings, and is differentiated by its proprietary Amino Taste Modification Technology (ATMT) that improves palatability while preserving clinical efficacy. Products are sold directly to consumers via the company's e-commerce site, with subscription options and HSA/FSA eligibility, complemented by free concierge clinical support and a structured LFE food reintroduction plan.

Product overview

mBIOTA Labs offers a portfolio of medical food products centered on the mBIOTA Elemental Diet — a clinically proven elemental nutrition system for managing gastrointestinal conditions. The core product is the 2-Week Protocol (84 servings, $750), a 14-day sole-source nutrition program clinically trialed at Cedars-Sinai. Supporting products include the 1-Week Extension ($375) for protocol extension or flare management, and the Maintenance Plan ($250) for ongoing nutritional support. The company differentiates through its proprietary Amino Taste Modification Technology (ATMT) for improved palatability, and offers complementary services including free concierge clinical support calls and a structured Low Fermentation Eating transition guide. Products are available in Original (tropical vanilla) and Orange flavors, and are HSA/FSA eligible through Truemed integration.

Differentiator

Problem solved

Functional benefit

Products and services

• mBIOTA Elemental Diet: 2-Week Protocol A 14-day sole-source elemental nutrition program providing 84 servings designed to rest the digestive system, support GI relief, and help eradicate bacterial overgrowth. Targeted at patients with SIBO, IMO, IBS, IBD, and EoE under medical supervision; clinically trialed at Cedars-Sinai with 83% SIBO eradication rate and 100% protocol completion rate.
• mBIOTA Elemental Diet: 1-Week Extension A 7-day, 42-serving extension to the 2-Week Protocol that adds flexibility for protocol extension, supplemental nutrition during digestive rest, or flare management. Available as a one-time purchase ($375) or monthly subscription ($300, 20% off).
• mBIOTA Elemental Diet: Maintenance Plan A maintenance product providing 24 individual servings designed for supplemental nutrition to maintain remission, manage flares, or provide ongoing dietary support for GI conditions. Available as a one-time purchase ($250) or monthly subscription ($200, 20% off).

Quantifiable outcome

• 83% of SIBO patients eradicated their bacterial overgrowth after 2-week protocol
• +4 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature2 records

Partnerships

Six partnerships are on record, tiered core and strategic.

• Cedars-Sinai Medical CentercoreStrategic or Co-development Partner · 1 January 2023Clinical research partnership with Cedars-Sinai's Motility Clinic led by Dr. Ali Rezaie and Dr. Mark Pimentel. Conducted the first prospective clinical trial of mBIOTA Elemental for SIBO and IMO patients in 2023, demonstrating 83% eradication rate and 100% completion rate. Results published in Clinical Gastroenterology and Hepatology.
• TruemedcoreGTM or Marketing PartnerPartnership enabling HSA/FSA eligibility for mBIOTA purchases. Truemed provides Letter of Medical Necessity assessments through licensed providers, allowing customers to use pre-tax healthcare dollars for purchases with approximately 30% average savings.
• SIBO Awareness / Gut Microbiome FoundationstrategicStrategic or Co-development PartnerProud SIBO Awareness Partner dedicated to educating patients and healthcare professionals about SIBO. Partnership focuses on advancing gut microbiome research, providing science-backed resources, and raising awareness about SIBO diagnosis and management.
• Dr. Mark PimentelcoreStrategic or Co-development PartnerGastroenterology physician-scientist and Medical Advisory Board member. Co-developed mBIOTA Elemental formula. Pioneer in SIBO and IBS research who developed the Low Fermentation Eating (LFE) diet. Has published in NEJM, JAMA, and other leading journals.
• Dr. Ali RezaiecoreStrategic or Co-development PartnerGastroenterology physician-scientist and Medical Advisory Board member. Co-developed mBIOTA Elemental formula. Lead investigator of Cedars-Sinai clinical trial. Has published 150+ peer-reviewed papers with 10,000+ citations. Associate editor of Digestive Diseases and Sciences journal.
• GoodLFEstrategicStrategic or Co-development PartnerSister company providing personalized Low Fermentation Eating resources and GI dietitian services. Referenced on mBIOTA website for patients seeking deeper food-specific guidance during transition back to solid foods.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Vivante Health: Vivante Health is a digital therapeutic platform for digestive diseases (IBS, IBD) combining app-based care with personalized nutrition. Comparable as a digitally delivered, condition-specific GI health solution targeting the same patient population via a different modality.
• Klaire Labs (SFI Health): Klaire Labs is a practitioner-grade supplement brand offering probiotics, enzymes, and GI-targeted formulas. Comparable as a clinical-channel nutrition company addressing gut microbiome restoration, overlapping with mBIOTA's digestive health focus.
• Atrantil: Atrantil is an over-the-counter botanical supplement formulated specifically for SIBO and bloating. Directly comparable as an evidence-backed, condition-specific GI product targeting the same SIBO use case as mBIOTA's elemental diet.

Direct peers

• Fody Food Co. Fody sells low-FODMAP specialty food products (sauces, snacks, pasta) targeted at IBS and digestive-condition sufferers. Comparable as a D2C brand providing gut-friendly specialty foods for the same patient demographic.
• Modify Health: Modify Health delivers medically tailored meals (low-FODMAP, Mediterranean, gluten-free) prescribed by physicians for GI conditions. Directly comparable as a DTC medical food company targeting SIBO/IBS/IBD patients with subscription meal programs backed by clinical evidence.
• Epicured: Epicured offers low-FODMAP and gluten-free prepared meals designed for patients with IBS, IBD, and other GI disorders. Comparable as a DTC subscription meal service addressing the same gut-health patient population with physician-recommended nutrition.

Broad incumbents

• Nestlé Health Science (Vivonex): Nestlé Health Science owns Vivonex, the most widely prescribed elemental diet formula. Directly competing in the elemental diet category at much larger scale with established physician detailing and hospital formulary access; an incumbent mBIOTA must displace or differentiate against.
• Abbott Nutrition (Vital / PediaSure): Abbott Nutrition sells medical nutrition products including elemental and semi-elemental formulas under brands like Vital. A large-scale incumbent in medical foods with formulary access that competes in the same underlying category as mBIOTA.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@mbiotaelemental
• Instagraminstagram.com/mbiotaelemental
• TikToktiktok.com/@mbiotaelemental
• Xx.com/mbiotaelemental
• Facebookfacebook.com/mbiotaelemental
• LinkedInlinkedin.com/company/mbiota-labs

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about mBIOTA Labs